Novartis Farmacéutica

About Novartis Farmacéutica

Novartis Farmacéutica is a leading global healthcare company based in the UK, dedicated to reimagining medicine to improve and extend people’s lives. With a strong commitment to innovation, Novartis focuses on developing breakthrough treatments that address unmet medical needs across various therapeutic areas.

The company operates through two main divisions: Innovative Medicines and Sandoz. The Innovative Medicines division encompasses patented pharmaceuticals, including advanced therapies for oncology, cardiology, immunology, and neuroscience. Meanwhile, Sandoz specializes in generic and biosimilar medicines, ensuring access to high-quality healthcare solutions worldwide.

At Novartis, we believe in the power of science and technology to transform healthcare. Our research and development efforts are driven by a passion for discovering new therapies that can change the course of diseases. We collaborate with healthcare professionals, patients, and partners to foster innovation and bring new treatments to market.

Our vision is to be a trusted leader in the pharmaceutical industry, known for our integrity, quality, and commitment to patient-centric care. We strive to create a diverse and inclusive workplace where every employee can contribute to our mission of improving health outcomes.

In addition to our focus on innovative therapies, Novartis is committed to sustainability and corporate responsibility. We actively engage in initiatives that promote environmental stewardship and social impact, ensuring that our operations benefit not only patients but also the communities we serve.

With a rich history and a forward-looking approach, Novartis Farmacéutica continues to push the boundaries of science and medicine, aiming to make a meaningful difference in the lives of patients around the globe.